Is high-dose estrogen-induced osteogenesis in the mouse mediated by an estrogen receptor? - PubMed (original) (raw)
Is high-dose estrogen-induced osteogenesis in the mouse mediated by an estrogen receptor?
A Samuels et al. Bone. 2000 Jul.
Abstract
Although estrogen is known to induce new bone formation in the long bones of female mice, this response is only thought to occur following administration of high doses, suggesting that it may not be mediated by a conventional estrogen receptor. To address this question further, we first examined the stereospecificity of this response by comparing the potency of 17beta-estradiol (E(2)) in stimulating cancellous bone formation at the proximal tibial metaphysis of intact female mice with that of the relatively inactive stereoisomer, 17alpha-estradiol (alphaE(2)). We found that E(2) was significantly more potent than alphaE(2), as assessed by histomorphometry. To provide further evidence for an estrogen-receptor-mediated process, we examined whether E(2)-induced osteogenesis in intact female mice could be inhibited by the estrogen receptor antagonist, ICI 182,780 (ICI). Although ICI itself had no effect on histomorphometric indices of the proximal tibial metaphysis when given alone, it significantly inhibited the osteogenic response to E(2). Finally, we examined the dose dependency of E(2)-induced osteogenesis at the proximal tibial metaphysis in intact mice. We found that E(2) stimulated cancellous bone formation in a dose-dependent manner over a wide dose range (i. e., 1-4000 microg/kg per day), with significant increases observed at doses of 4 microg/kg per day and beyond. Our results raise the possibility that estrogen-induced osteogenesis in the mouse represents an estrogen-receptor-mediated response that is not confined solely to supraphysiological estrogen levels.
Similar articles
- Role of endothelial nitric oxide synthase in estrogen-induced osteogenesis.
Samuels A, Perry MJ, Gibson RL, Colley S, Tobias JH. Samuels A, et al. Bone. 2001 Jul;29(1):24-9. doi: 10.1016/s8756-3282(01)00471-9. Bone. 2001. PMID: 11472887 - High-dose estrogen-induced osteogenesis in the mouse is partially suppressed by indomethacin.
Samuels A, Perry MJ, Tobias JH. Samuels A, et al. Bone. 1999 Dec;25(6):675-80. doi: 10.1016/s8756-3282(99)00226-4. Bone. 1999. PMID: 10593412 - Estrogen-induced osteogenesis in intact female mice lacking ERbeta.
McDougall KE, Perry MJ, Gibson RL, Bright JM, Colley SM, Hodgin JB, Smithies O, Tobias JH. McDougall KE, et al. Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E817-23. doi: 10.1152/ajpendo.00071.2002. Am J Physiol Endocrinol Metab. 2002. PMID: 12217900 - Estrogen receptor-alpha dependency of estrogen's stimulatory action on cancellous bone formation in male mice.
McDougall KE, Perry MJ, Gibson RL, Colley SM, Korach KS, Tobias JH. McDougall KE, et al. Endocrinology. 2003 May;144(5):1994-9. doi: 10.1210/en.2002-0074. Endocrinology. 2003. PMID: 12697707 - High-dose estrogen induces de novo medullary bone formation in female mice.
Samuels A, Perry MJ, Tobias JH. Samuels A, et al. J Bone Miner Res. 1999 Feb;14(2):178-86. doi: 10.1359/jbmr.1999.14.2.178. J Bone Miner Res. 1999. PMID: 9933470
Cited by
- Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis.
Lyu Z, Hu Y, Guo Y, Liu D. Lyu Z, et al. Bone Res. 2023 Jun 9;11(1):31. doi: 10.1038/s41413-023-00264-x. Bone Res. 2023. PMID: 37296111 Free PMC article. Review. - Estrogen signaling in arcuate Kiss1 neurons suppresses a sex-dependent female circuit promoting dense strong bones.
Herber CB, Krause WC, Wang L, Bayrer JR, Li A, Schmitz M, Fields A, Ford B, Zhang Z, Reid MS, Nomura DK, Nissenson RA, Correa SM, Ingraham HA. Herber CB, et al. Nat Commun. 2019 Jan 11;10(1):163. doi: 10.1038/s41467-018-08046-4. Nat Commun. 2019. PMID: 30635563 Free PMC article. - Constructing the toolbox: Patient-specific genetic factors of altered fracture healing.
Drissi H, Paglia DN, Alaee F, Yoshida R. Drissi H, et al. Genes Dis. 2014 Dec 1;1(2):140-148. doi: 10.1016/j.gendis.2014.07.006. Genes Dis. 2014. PMID: 25558470 Free PMC article. - Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass.
Bartell SM, Han L, Kim HN, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS, Chambliss KL, Shaul PW, Roberson PK, Weinstein RS, Jilka RL, Almeida M, Manolagas SC. Bartell SM, et al. Mol Endocrinol. 2013 Apr;27(4):649-56. doi: 10.1210/me.2012-1368. Epub 2013 Feb 26. Mol Endocrinol. 2013. PMID: 23443267 Free PMC article. - Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts.
Seitz S, Keller J, Schilling AF, Jeschke A, Marshall RP, Stride BD, Wintermantel T, Beil FT, Amling M, Schütz G, Tuckermann J, Schinke T. Seitz S, et al. PLoS One. 2012;7(11):e50301. doi: 10.1371/journal.pone.0050301. Epub 2012 Nov 27. PLoS One. 2012. PMID: 23209701 Free PMC article.